过度表达SYK增强了MDA-MB-231衍生的抗帕克利塔塞尔细胞系中的微管不稳定性
Hsiao-Hui Kuo1, Chien-Wei Huang1, Wei-Rou Chiang1
1Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan.
Biochimica et biophysica acta. Molecular cell research
|September 10, 2025
概括
耐帕克利塔塞尔三阴性乳腺癌细胞需要帕克利塔塞尔生存,这是由于脏氨酸激酶 (SYK) 增强的微管不稳定性. 准SYK或诱导铁死可以克服这种抵抗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 帕克利塔克塞尔耐药性是治疗三阴性乳腺癌 (TNBC) 的重大挑战.
- 开发克服药物耐药性的策略对于改善患者的治疗结果至关重要.
研究的目的:
- 研究TNBC中帕克利塔克塞尔耐药性背后的机制.
- 为了确定克服帕克利塔克塞尔耐药性的潜在治疗点.
主要方法:
- 从MDA-MD-231细胞中建立了一种抗帕克利塔塞尔的TNBC细胞系 (T50R).
- 分析了微管 (MT) 动力学,线索形成和细胞死亡途径.
- 评估了腺氨酸激酶 (SYK) 和内质网膜 (ER) 压力的作用.
主要成果:
- 在没有帕克利塔塞尔的情况下,T50R细胞表现出MT过度不稳定性和线粒性结,需要药物进行增殖.
- 在T50R细胞中发现了SYK过度表达,导致MT不稳定.
- 抑制SYK恢复了MT稳定性,减少了细胞死亡,并改善了T50R细胞中的ER应激和铁亡.
- 向SYK或诱导铁亡,增强了T50R细胞对帕克利塔塞尔的敏感性.
结论:
- 由SYK驱动的MT动态不稳定性在TNBC中帕克利塔塞尔耐药性中起着关键作用.
- 准SYK途径和铁死是一种潜在的策略,可以提高抗药性TNBC中帕克利塔塞尔的疗效.
相关概念视频
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Microtubule Instability
6.0K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
6.0K
Destabilization of Microtubules
3.5K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.5K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


